Xin Luo1, Junjun Dong1, Xingyue He1, Lianju Shen1, Chunlan Long1, Feng Liu1, Xing Liu1, Tao Lin1, Dawei He1, Guanghui Wei1. 1. Department of Pediatric Urologic Surgery, Children's Hospital of Chongqing Medical University; Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.
Abstract
OBJECTIVE: explore the expression of miR-155-5p in Wilms tumor and its effect in regulating the proliferation, migration and apoptosis of Wilms tumor cells. METHODS: Specimens of tumor tissues and paired adjacent tissues were obtained from 40 patients with Wilms tumor for detection of the expression levels of miR-155-5p using RT-qPCR. Wilms tumor cell line G401 was transfected with miR-155-5p mimics and miR-155-5p inhibitor to induce miR-155-5p over-expression and its inhibition, respectively, and the changes in the cell proliferation, migration and apoptosis were assessed using cell counting kit-8 (CCK-8), wound healing assay and fl ow cytometry. RESULTS: RT-qPCR showed that the expression of miR-155-5p decreased significantly in Wilms tumor tissues as compared with normal kidney tissues and was significantly associated with TNM stage (P < 0.05). In G401 cells, over-expression of miR-155-5p significantly inhibited the cell proliferation and migration and promoted cell apoptosis (P < 0.05), and down-regulation of miR-155-5p obviously enhanced the proliferation and migration and suppressed apoptosis of the cells (P < 0.05). CONCLUSIONS: miR-155-5p is down-regulated in Wilms tumor and its expression level is correlated with TNM stage. miR-155-5p participates in the progression of Wilms tumor by inhibiting the proliferation and migration and promoting apoptosis of the tumor cells, and may serve as a novel biomarker for diagnosis, therapy and prognostic evaluation of Wilms tumor.
OBJECTIVE: explore the expression of miR-155-5p in Wilms tumor and its effect in regulating the proliferation, migration and apoptosis of Wilms tumor cells. METHODS: Specimens of tumor tissues and paired adjacent tissues were obtained from 40 patients with Wilms tumor for detection of the expression levels of miR-155-5p using RT-qPCR. Wilms tumor cell line G401 was transfected with miR-155-5p mimics and miR-155-5p inhibitor to induce miR-155-5p over-expression and its inhibition, respectively, and the changes in the cell proliferation, migration and apoptosis were assessed using cell counting kit-8 (CCK-8), wound healing assay and fl ow cytometry. RESULTS: RT-qPCR showed that the expression of miR-155-5p decreased significantly in Wilms tumor tissues as compared with normal kidney tissues and was significantly associated with TNM stage (P < 0.05). In G401 cells, over-expression of miR-155-5p significantly inhibited the cell proliferation and migration and promoted cell apoptosis (P < 0.05), and down-regulation of miR-155-5p obviously enhanced the proliferation and migration and suppressed apoptosis of the cells (P < 0.05). CONCLUSIONS:miR-155-5p is down-regulated in Wilms tumor and its expression level is correlated with TNM stage. miR-155-5p participates in the progression of Wilms tumor by inhibiting the proliferation and migration and promoting apoptosis of the tumor cells, and may serve as a novel biomarker for diagnosis, therapy and prognostic evaluation of Wilms tumor.
Authors: Bodo Brueckner; Carlo Stresemann; Ruprecht Kuner; Cora Mund; Tanja Musch; Michael Meister; Holger Sültmann; Frank Lyko Journal: Cancer Res Date: 2007-02-15 Impact factor: 12.701
Authors: Clare Turnbull; Elizabeth R Perdeaux; David Pernet; Arlene Naranjo; Anthony Renwick; Sheila Seal; Rosa Maria Munoz-Xicola; Sandra Hanks; Ingrid Slade; Anna Zachariou; Margaret Warren-Perry; Elise Ruark; Mary Gerrard; Juliet Hale; Martin Hewitt; Janice Kohler; Sheila Lane; Gill Levitt; Mabrook Madi; Bruce Morland; Veronica Neefjes; James Nicholson; Susan Picton; Barry Pizer; Milind Ronghe; Michael Stevens; Heidi Traunecker; Charles A Stiller; Kathy Pritchard-Jones; Jeffrey Dome; Paul Grundy; Nazneen Rahman Journal: Nat Genet Date: 2012-04-29 Impact factor: 38.330
Authors: Kenneth S Chen; Emily K Stroup; Albert Budhipramono; Dinesh Rakheja; Diana Nichols-Vinueza; Lin Xu; Sarai H Stuart; Abhay A Shukla; Claudette Fraire; Joshua T Mendell; James F Amatruda Journal: Genes Dev Date: 2018-07-19 Impact factor: 11.361